Tycho Peterson
Stock Analyst at Jefferies
(4.45)
# 195
Out of 4,479 analysts
122
Total ratings
62.03%
Success rate
13.83%
Average return
Main Sectors:
35 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACB Pacific Biosciences of California | Initiates: Buy | n/a | $1.28 | - | 3 | Jun 3, 2024 | |
| NAUT Nautilus Biotechnology | Assumes: Hold | $5 → $3 | $2.27 | +32.16% | 1 | Jun 3, 2024 | |
| NTRA Natera | Initiates: Buy | $142 | $110.70 | +28.27% | 3 | Jun 3, 2024 | |
| GH Guardant Health | Initiates: Buy | $32 | $28.87 | +10.84% | 2 | Jun 3, 2024 | |
| TXG 10x Genomics | Initiates: Hold | n/a | $18.87 | - | 6 | Jun 3, 2024 | |
| ILMN Illumina | Assumes: Hold | $115 | $105.51 | +8.99% | 1 | Jun 3, 2024 | |
| MYGN Myriad Genetics | Assumes: Underperform | $25 → $20 | $24.76 | -19.22% | 1 | Jun 3, 2024 | |
| TMO Thermo Fisher | Assumes: Buy | $600 → $650 | $533.93 | +21.74% | 12 | Jun 3, 2024 | |
| MTD Mettler-Toledo International | Assumes: Underperform | $1,230 → $1,250 | $1,357.07 | -7.89% | 7 | Jun 3, 2024 | |
| ICLR ICON PLC | Maintains: Overweight | $295 → $330 | $318.30 | +3.68% | 2 | Dec 20, 2023 | |
| NVST Envista Holdings | Maintains: Overweight | $42 → $32 | $16.34 | +95.84% | 4 | Nov 2, 2023 | |
| SHC Sotera Health Company | Downgrades: Underweight | $26 → $9 | $11.63 | -22.61% | 1 | Sep 21, 2022 | |
| RPID Rapid Micro Biosystems | Downgrades: Neutral | n/a | $0.64 | - | 2 | Aug 16, 2022 | |
| SEER Seer, Inc. | Downgrades: Neutral | $20 → $12 | $1.64 | +631.71% | 2 | Aug 11, 2022 | |
| QTRX Quanterix | Maintains: Overweight | $85 → $60 | $12.72 | +371.70% | 2 | Mar 2, 2022 | |
| TLIS Talis Biomedical | Downgrades: Underweight | $150 → $105 | $8.50 | +1,135.29% | 3 | Sep 27, 2021 | |
| SOPH SOPHiA GENETICS | Initiates: Overweight | $23 | $4.59 | +401.09% | 1 | Aug 17, 2021 | |
| OMIC Singular Genomics Systems | Initiates: Overweight | $900 | $8.51 | +10,475.79% | 1 | Jun 21, 2021 | |
| QDEL QuidelOrtho | Maintains: Underweight | n/a | $31.36 | - | 2 | Jun 4, 2021 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $375 → $390 | $201.48 | +93.57% | 5 | May 28, 2021 | |
| A Agilent Technologies | Maintains: Overweight | $140 → $150 | $125.78 | +19.26% | 7 | May 26, 2021 | |
| AKYA Akoya Biosciences | Initiates: Overweight | $23 | $2.18 | +955.05% | 1 | May 11, 2021 | |
| TWST Twist Bioscience | Downgrades: Underweight | $100 | $47.32 | +111.33% | 2 | Feb 5, 2021 | |
| QGEN Qiagen | Reinstates: Overweight | $62 | $40.70 | +51.84% | 4 | Aug 20, 2020 | |
| OSUR OraSure Technologies | Initiates: Neutral | $18 | $4.08 | +341.18% | 1 | Aug 10, 2020 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $188 → $200 | $438.81 | -54.42% | 9 | Jun 18, 2020 | |
| HOLX Hologic | Maintains: Overweight | $60 → $50 | $73.53 | -32.00% | 6 | Mar 17, 2020 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $65 → $45 | $24.44 | +84.12% | 5 | Mar 17, 2020 | |
| AXDX Accelerate Diagnostics | Downgrades: Underweight | $160 | $1.15 | +13,813.04% | 4 | Sep 27, 2019 | |
| WAT Waters | Downgrades: Underweight | $185 → $180 | $284.49 | -36.73% | 6 | Dec 12, 2018 | |
| RGEN Repligen | Maintains: Overweight | $60 → $70 | $120.14 | -41.73% | 2 | Nov 2, 2018 | |
| IQV IQVIA Holdings | Maintains: Overweight | $115 → $120 | $207.47 | -42.16% | 1 | Feb 15, 2018 | |
| ARAY Accuray | Downgrades: Underweight | n/a | $1.75 | - | 7 | Dec 13, 2017 | |
| BRKR Bruker | Downgrades: Neutral | n/a | $61.64 | - | 5 | Nov 3, 2017 | |
| MBLY Mobileye | Initiates: Neutral | $55 | $27.89 | +97.20% | 1 | Jul 19, 2016 |
Pacific Biosciences of California
Jun 3, 2024
Initiates: Buy
Price Target: n/a
Current: $1.28
Upside: -
Nautilus Biotechnology
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $2.27
Upside: +32.16%
Natera
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $110.70
Upside: +28.27%
Guardant Health
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $28.87
Upside: +10.84%
10x Genomics
Jun 3, 2024
Initiates: Hold
Price Target: n/a
Current: $18.87
Upside: -
Illumina
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $105.51
Upside: +8.99%
Myriad Genetics
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $24.76
Upside: -19.22%
Thermo Fisher
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $533.93
Upside: +21.74%
Mettler-Toledo International
Jun 3, 2024
Assumes: Underperform
Price Target: $1,230 → $1,250
Current: $1,357.07
Upside: -7.89%
ICON PLC
Dec 20, 2023
Maintains: Overweight
Price Target: $295 → $330
Current: $318.30
Upside: +3.68%
Envista Holdings
Nov 2, 2023
Maintains: Overweight
Price Target: $42 → $32
Current: $16.34
Upside: +95.84%
Sotera Health Company
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $11.63
Upside: -22.61%
Rapid Micro Biosystems
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.64
Upside: -
Seer, Inc.
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.64
Upside: +631.71%
Quanterix
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $12.72
Upside: +371.70%
Talis Biomedical
Sep 27, 2021
Downgrades: Underweight
Price Target: $150 → $105
Current: $8.50
Upside: +1,135.29%
SOPHiA GENETICS
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.59
Upside: +401.09%
Singular Genomics Systems
Jun 21, 2021
Initiates: Overweight
Price Target: $900
Current: $8.51
Upside: +10,475.79%
QuidelOrtho
Jun 4, 2021
Maintains: Underweight
Price Target: n/a
Current: $31.36
Upside: -
Charles River Laboratories International
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $201.48
Upside: +93.57%
Agilent Technologies
May 26, 2021
Maintains: Overweight
Price Target: $140 → $150
Current: $125.78
Upside: +19.26%
Akoya Biosciences
May 11, 2021
Initiates: Overweight
Price Target: $23
Current: $2.18
Upside: +955.05%
Twist Bioscience
Feb 5, 2021
Downgrades: Underweight
Price Target: $100
Current: $47.32
Upside: +111.33%
Qiagen
Aug 20, 2020
Reinstates: Overweight
Price Target: $62
Current: $40.70
Upside: +51.84%
OraSure Technologies
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $4.08
Upside: +341.18%
Intuitive Surgical
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $438.81
Upside: -54.42%
Hologic
Mar 17, 2020
Maintains: Overweight
Price Target: $60 → $50
Current: $73.53
Upside: -32.00%
DENTSPLY SIRONA
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $24.44
Upside: +84.12%
Accelerate Diagnostics
Sep 27, 2019
Downgrades: Underweight
Price Target: $160
Current: $1.15
Upside: +13,813.04%
Waters
Dec 12, 2018
Downgrades: Underweight
Price Target: $185 → $180
Current: $284.49
Upside: -36.73%
Repligen
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $120.14
Upside: -41.73%
IQVIA Holdings
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $207.47
Upside: -42.16%
Accuray
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.75
Upside: -
Bruker
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $61.64
Upside: -
Mobileye
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $27.89
Upside: +97.20%